Digital Diagnostics Inc. is a trailblazing company that uses artificial intelligence (AI) to revolutionize the medical diagnosis and treatment process. The company's primary goal is to make healthcare more accessible, affordable, and equitable for patients worldwide. They aim to achieve this by integrating technology into healthcare, thereby improving the quality of care and patient outcomes.

The company operates in the healthcare technology market, specifically in the AI diagnostics sector. Their primary clients are healthcare providers who use their technology to diagnose and treat patients. One of their key products is LumineticsCore, an AI diagnostic system that autonomously diagnoses patients for diabetic retinopathy, a condition that can lead to vision loss in people with diabetes. This system not only helps doctors prevent vision loss from diabetes but also improves their quality scores, making it an attractive tool for healthcare providers.

Digital Diagnostics Inc. makes money by selling their AI diagnostic systems to healthcare providers. Their business model revolves around developing and marketing cutting-edge AI platforms that can diagnose and treat medical conditions autonomously, thereby improving patient outcomes and making healthcare more efficient.

In summary, Digital Diagnostics Inc. is a pioneering AI diagnostics company that aims to transform global healthcare by making it more accessible, affordable, and equitable. They develop and sell AI diagnostic systems to healthcare providers, with a focus on improving patient outcomes and healthcare efficiency.

Keywords: AI diagnostics, healthcare technology, diabetic retinopathy, autonomous diagnosis, patient outcomes, global healthcare, accessibility, affordability, equity, cutting-edge technology.